Esterase mutation is a mechanism of resistance to antimalarial compounds

Pepstatin is a known inhibitor of malarial proteases, but its activity varies between sources. Here, Istvanet al. identify a pepstatin ester as the active component of pepstatin preparations and show that this prodrug is activated by a Plasmodiumesterase, mutation of which can confer resistance to p...

Full description

Bibliographic Details
Main Authors: Eva S. Istvan, Jeremy P. Mallari, Victoria C. Corey, Neekesh V. Dharia, Garland R. Marshall, Elizabeth A. Winzeler, Daniel E. Goldberg
Format: Article
Language:English
Published: Nature Publishing Group 2017-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms14240
id doaj-1d38f9612f4048a39eb045aecf7bcf36
record_format Article
spelling doaj-1d38f9612f4048a39eb045aecf7bcf362021-05-11T07:09:06ZengNature Publishing GroupNature Communications2041-17232017-01-01811810.1038/ncomms14240Esterase mutation is a mechanism of resistance to antimalarial compoundsEva S. Istvan0Jeremy P. Mallari1Victoria C. Corey2Neekesh V. Dharia3Garland R. Marshall4Elizabeth A. Winzeler5Daniel E. Goldberg6Department of Medicine, Division of Infectious Diseases, Washington University School of MedicineDepartment of Medicine, Division of Infectious Diseases, Washington University School of MedicineDepartment of Pediatrics, School of Medicine, University of California San Diego School of MedicineDepartment of Pediatrics, School of Medicine, University of California San Diego School of MedicineDepartment of Biochemistry and Molecular Biophysics, Washington University School of MedicineDepartment of Pediatrics, School of Medicine, University of California San Diego School of MedicineDepartment of Medicine, Division of Infectious Diseases, Washington University School of MedicinePepstatin is a known inhibitor of malarial proteases, but its activity varies between sources. Here, Istvanet al. identify a pepstatin ester as the active component of pepstatin preparations and show that this prodrug is activated by a Plasmodiumesterase, mutation of which can confer resistance to pepstatin and other compounds.https://doi.org/10.1038/ncomms14240
collection DOAJ
language English
format Article
sources DOAJ
author Eva S. Istvan
Jeremy P. Mallari
Victoria C. Corey
Neekesh V. Dharia
Garland R. Marshall
Elizabeth A. Winzeler
Daniel E. Goldberg
spellingShingle Eva S. Istvan
Jeremy P. Mallari
Victoria C. Corey
Neekesh V. Dharia
Garland R. Marshall
Elizabeth A. Winzeler
Daniel E. Goldberg
Esterase mutation is a mechanism of resistance to antimalarial compounds
Nature Communications
author_facet Eva S. Istvan
Jeremy P. Mallari
Victoria C. Corey
Neekesh V. Dharia
Garland R. Marshall
Elizabeth A. Winzeler
Daniel E. Goldberg
author_sort Eva S. Istvan
title Esterase mutation is a mechanism of resistance to antimalarial compounds
title_short Esterase mutation is a mechanism of resistance to antimalarial compounds
title_full Esterase mutation is a mechanism of resistance to antimalarial compounds
title_fullStr Esterase mutation is a mechanism of resistance to antimalarial compounds
title_full_unstemmed Esterase mutation is a mechanism of resistance to antimalarial compounds
title_sort esterase mutation is a mechanism of resistance to antimalarial compounds
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2017-01-01
description Pepstatin is a known inhibitor of malarial proteases, but its activity varies between sources. Here, Istvanet al. identify a pepstatin ester as the active component of pepstatin preparations and show that this prodrug is activated by a Plasmodiumesterase, mutation of which can confer resistance to pepstatin and other compounds.
url https://doi.org/10.1038/ncomms14240
work_keys_str_mv AT evasistvan esterasemutationisamechanismofresistancetoantimalarialcompounds
AT jeremypmallari esterasemutationisamechanismofresistancetoantimalarialcompounds
AT victoriaccorey esterasemutationisamechanismofresistancetoantimalarialcompounds
AT neekeshvdharia esterasemutationisamechanismofresistancetoantimalarialcompounds
AT garlandrmarshall esterasemutationisamechanismofresistancetoantimalarialcompounds
AT elizabethawinzeler esterasemutationisamechanismofresistancetoantimalarialcompounds
AT danielegoldberg esterasemutationisamechanismofresistancetoantimalarialcompounds
_version_ 1721452733260627968